G. C. Schito

1.3k total citations
33 papers, 1.0k citations indexed

About

G. C. Schito is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, G. C. Schito has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Clinical Biochemistry. Recurrent topics in G. C. Schito's work include Antimicrobial Resistance in Staphylococcus (10 papers), Pneumonia and Respiratory Infections (9 papers) and Bacterial Identification and Susceptibility Testing (8 papers). G. C. Schito is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Pneumonia and Respiratory Infections (9 papers) and Bacterial Identification and Susceptibility Testing (8 papers). G. C. Schito collaborates with scholars based in Italy, Germany and France. G. C. Schito's co-authors include Kurt G. Naber, Henry Botto, Juan Palou, Teresita Mazzei, Anna Marchese, Eugenio A. Debbia, L. Gualco, Anna Maria Schito, Pietro E. Varaldo and S. Mannelli and has published in prestigious journals such as Cellular and Molecular Life Sciences, European Urology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

G. C. Schito

33 papers receiving 949 citations

Peers

G. C. Schito
M J Robbins United Kingdom
Kim Nichol Canada
Virginia H. Morthland United States
G. M. Kalmanson United States
Iain J. Abbott Australia
Bianca Graves Australia
G. C. Schito
Citations per year, relative to G. C. Schito G. C. Schito (= 1×) peers Tetsuro Muratani

Countries citing papers authored by G. C. Schito

Since Specialization
Citations

This map shows the geographic impact of G. C. Schito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. C. Schito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. C. Schito more than expected).

Fields of papers citing papers by G. C. Schito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. C. Schito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. C. Schito. The network helps show where G. C. Schito may publish in the future.

Co-authorship network of co-authors of G. C. Schito

This figure shows the co-authorship network connecting the top 25 collaborators of G. C. Schito. A scholar is included among the top collaborators of G. C. Schito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. C. Schito. G. C. Schito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neuzillet, Y., Kurt G. Naber, G. C. Schito, L. Gualco, & Henry Botto. (2012). French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy. Médecine et Maladies Infectieuses. 42(2). 66–75. 32 indexed citations
2.
Wagenlehner, Flo ri an, et al.. (2010). Klinik und Epidemiologie der unkomplizierten Zystitis bei Frauen: Deutsche Ergebnisse der ARESC-Studie. Urologe A. 49(2). 253–261. 3 indexed citations
3.
Naber, Kurt G., G. C. Schito, Henry Botto, Juan Palou, & Teresita Mazzei. (2008). Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. European Urology. 54(5). 1164–1178. 230 indexed citations
4.
Schito, Anna Maria, et al.. (2007). Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. International Journal of Antimicrobial Agents. 30(5). 415–421. 31 indexed citations
5.
Gualco, L., Anna Maria Schito, G. C. Schito, & Anna Marchese. (2007). In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. International Journal of Antimicrobial Agents. 29(6). 679–687. 10 indexed citations
6.
Schito, G. C.. (2006). The importance of the development of antibiotic resistance in Staphylococcus aureus. Clinical Microbiology and Infection. 12. 3–8. 226 indexed citations
7.
Schito, G. C., Guido Fadda, Stefano Boros, et al.. (2006). Bacterial Isolates from Severe Infections and Their Antibiotic Susceptibility Patterns in Italy: a Nationwide Study in the Hospital Setting. Journal of Chemotherapy. 18(6). 589–602. 42 indexed citations
8.
Marchese, Anna, Francesco Ardito, Guido Fadda, et al.. (2005). The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy. International Journal of Antimicrobial Agents. 26(1). 8–12. 15 indexed citations
9.
Marchisio, Paola, Laura Claut, Alessandro Rognoni, et al.. (2003). Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. The Pediatric Infectious Disease Journal. 22(3). 262–268. 43 indexed citations
10.
Schito, G. C.. (2003). Why fosfomycin trometamol as first line therapy for uncomplicated UTI?. International Journal of Antimicrobial Agents. 22. 79–83. 77 indexed citations
11.
Schito, G. C.. (2002). Is antimicrobial resistance also subject to globalization?. Clinical Microbiology and Infection. 8. 1–8. 28 indexed citations
12.
Marchese, Anna, et al.. (2001). Evaluation of Spontaneous Contamination of Ocular Medications. Chemotherapy. 47(4). 304–308. 4 indexed citations
14.
Debbia, Eugenio A., G. C. Schito, L. Gualco, et al.. (2001). Microbial Epidemiology Patterns of Surgical Infection Pathogens. Journal of Chemotherapy. 13(sup4). 84–88. 5 indexed citations
15.
Parenti, Francesca, G. C. Schito, & Patrice Courvalin. (2000). Teicoplanin Chemistry and Microbiology. Journal of Chemotherapy. 12(sup5). 5–14. 18 indexed citations
16.
Cattarini, G., et al.. (1997). Evaluation of the trophic effect of human placental polydeoxyribonucleotide on human knee skin fibroblasts in primary culture. Cellular and Molecular Life Sciences. 53(3). 279–285. 22 indexed citations
17.
Marchese, Anna, et al.. (1996). Detection of SHV-5 extended-spectrum beta-lactamase inKlebsiella pneumoniae strains isolated in Italy. European Journal of Clinical Microbiology & Infectious Diseases. 15(3). 245–248. 21 indexed citations
18.
Schito, G. C.. (1996). Introduction. Diagnostic Microbiology and Infectious Disease. 25(4). 151–152. 1 indexed citations
19.
Schito, G. C., Gian Luca Grazi, B Dainelli, et al.. (1994). Incidence of Lower Respiratory Tract Infections Caused by Mycoplasma, Chlamydia and Legionella: an Italian Multicenter Survey. Journal of Chemotherapy. 6(5). 319–321. 6 indexed citations
20.
Debbia, Eugenio A., A. Pesce, & G. C. Schito. (1986). In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. Journal of Hospital Infection. 7. 73–77. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026